Minnesota State Wire

[ST. PAUL, MN] – At a national biomedical industry convention in Boston, Governor Tim Walz yesterday highlighted Minnesota as a global leader in biomedical technology and promoted continued investment in the state.

“When it comes to biomedical technology and innovation, Minnesota leads the way. This was an opportunity to promote our world-class biomedical industry alongside national and global leaders who recognize the cutting-edge work we’re doing,” said Governor Walz. “I look forward to continue working with leaders in the biomedical industry to expand our partnerships, promote growth and investment, and ensure Minnesota is on the frontline of medical innovation.”

Governor Walz visited with leaders in the biomedical industry, including Philips Healthcare, Takeda Pharmecuticals, EcoLab, and Cytotheryx to discuss their investments in Minnesota and opportunities for continued partnership. He also met with members from Japan and Australia’s trade delegations. Governor Walz will lead a trade mission to Australia in November.

This event comes as Mayo Clinic announced a billion-dollar investment in Rochester. The Governor’s Office worked closely with Mayo to secure the expansion. The investment will create jobs, build on Minnesota’s reputation for world-class health care, attract businesses and investment in Rochester, and pave the way for Minnesota to lead in biomedical innovation.

Original source can be found here.